Frederick W. Driscoll

Overview

Frederick W. Driscoll received an average of $1M in total compensation, including $327K in salary, at Flexion Therapeutics from 2014 to 2016. Frederick Driscoll also received an average of $614K at Novavax from 2009 to 2012.

Related executives

We found 28 more executives who work or worked at Flexion Therapeutics and Novavax.

Stanley Erck

Novavax

Chief Executive Officer

Gregory Glenn

Novavax

President, Research and Development

John Trizzino

Novavax

Chief Financial Officer

John Herrmann

Novavax

Chief Legal Officer

Gregory Covino

Novavax

Chief Financial Officer

Michael Clayman

Flexion Therapeutics

Chief Executive Officer

David Arkowitz

Flexion Therapeutics

Chief Financial Officer

Neil Bodick

Flexion Therapeutics

Chief Scientific Officer

You may also like